Your browser doesn't support javascript.
loading
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Carrat, Fabrice; Fontaine, Hélène; Dorival, Céline; Simony, Mélanie; Diallo, Alpha; Hezode, Christophe; De Ledinghen, Victor; Larrey, Dominique; Haour, Georges; Bronowicki, Jean-Pierre; Zoulim, Fabien; Asselah, Tarik; Marcellin, Patrick; Thabut, Dominique; Leroy, Vincent; Tran, Albert; Habersetzer, François; Samuel, Didier; Guyader, Dominique; Chazouilleres, Olivier; Mathurin, Philippe; Metivier, Sophie; Alric, Laurent; Riachi, Ghassan; Gournay, Jérôme; Abergel, Armand; Cales, Paul; Ganne, Nathalie; Loustaud-Ratti, Véronique; D'Alteroche, Louis; Causse, Xavier; Geist, Claire; Minello, Anne; Rosa, Isabelle; Gelu-Simeon, Moana; Portal, Isabelle; Raffi, François; Bourliere, Marc; Pol, Stanislas.
Afiliação
  • Carrat F; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Unité de Santé Publique, Paris, France. Electronic address: fabric
  • Fontaine H; AP-HP, Hôpital Cochin, Unité d'Hépatologie, Paris, France.
  • Dorival C; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Simony M; ANRS (France Recherche Nord & Sud Sida-HIV Hépatites), Unit for Basic and Clinical Research on Viral Hepatitis, Paris, France.
  • Diallo A; Clinical Trial Safety and Public Health, Paris, France.
  • Hezode C; Department of Hepatology and Gastroenterology, Hôpital Henri Mondor, AP-HP, Université Paris-Est, INSERM U955, Créteil, France.
  • De Ledinghen V; Hepatology Unit Hôpital Haut-Lévêque, Pessac, and INSERM U1053, Université Bordeaux Segalen, Bordeaux, France.
  • Larrey D; Liver Unit, Institute for Regenerative Medicine and Biotherapy-INSERM 1183, Hôpital Saint Eloi, Montpellier, France.
  • Haour G; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Bronowicki JP; INSERM U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy Brabois, Université de Lorraine, Vandoeuvre-les-Nancy, France.
  • Zoulim F; Department of Hepatology, Hospices Civils de Lyon, INSERM U1052, Université de Lyon, Lyon, France.
  • Asselah T; INSERM, Hepatology, Hospital Beaujon, Centre de Recherche sur l'Inflammation (CRI), University Paris Diderot, Clichy, France.
  • Marcellin P; INSERM, Hepatology, Hospital Beaujon, Centre de Recherche sur l'Inflammation (CRI), University Paris Diderot, Clichy, France.
  • Thabut D; Sorbonne Université, Department of Hepatology and Gastroenterology, Groupe Hospitalier Pitié-Salpétrière, AP-HP, INSERM Unité Mixte de Recherche (UMR)-S938, Paris, France.
  • Leroy V; Department of Hepatology and Gastroenterology, Centre Hospitalier Universitaire (CHU), INSERM U1209, Université Grenoble Alpes, Grenoble, France.
  • Tran A; Digestive Centre, CHU de Nice, INSERM U1065-8, Nice, France.
  • Habersetzer F; Centre d'Investigation Clinique (CIC), INSERM 1110, and Pôle Hépato-digestif des Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
  • Samuel D; AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Université Paris-Sud, UMR-S1193, Université Paris-Saclay, and Hepatinov, Villejuif, France.
  • Guyader D; CHU de Rennes, Service d'Hépatologie, University Rennes 1, L'Institut National de la Recherche Agronomique (INRA), INSERM, Institut NUMECAN (Nutrition, Métabolismes et Cancer), UMR-A1341, and UMR-S1241, Rennes, France.
  • Chazouilleres O; Department of Hepatology, Hôpital Saint-Antoine, AP-HP, Sorbonne Université, Paris, France.
  • Mathurin P; Service des Maladies de l'Appareil Digestif, Université Lille 2, and INSERM U795, Lille, France.
  • Metivier S; Department of Hepatology and Gastroenterology, CHU Purpan, Toulouse, France.
  • Alric L; Department of Internal Medicine and Digestive Diseases, CHU Purpan, Toulouse, France; UMR 152 PHARMA-DEV (Pharmacochimie et Biologie pour le Développement), Institut de Recherche pour le Développement (IRD)-Université Toulouse 3, Toulouse, France.
  • Riachi G; Department of Hepatology and Gastroenterology, CHU Charles Nicolle, Rouen, France.
  • Gournay J; Gastroenterology and Hepatology Department, Institut des Maladies de l'Appareil Digestif, University Hospital Nantes, Nantes, France.
  • Abergel A; Department of Digestive and Hepatobiliary Diseases, Estaing University Hospital, and UMR Auvergne University, Centre National de la Recherche Scientifique (CNRS) 6284 ISIT (Image Sciences for Innovations Techniques), Clermont-Ferrand, France.
  • Cales P; Hepatology Department, University Hospital, Angers, France; Hémodynamique, Interaction Fibrose et Invasivité Tumorales Hépatiques (HIFIH) Laboratory, Bretagne Loire University, Angers, France.
  • Ganne N; Department of Hepatology, Hôpitaux Universitaires Paris Seine-Saint-Denis, site Jean Verdier, AP-HP, Bondy, France; Université Paris 13, Sorbonne Paris Cité et INSERM UMR 1162, Paris, France.
  • Loustaud-Ratti V; Department of Hepatology and Gastroenterology, CHU Limoges, INSERM U1248, Université de Limoges, Limoges, France.
  • D'Alteroche L; Unit of Hepatology, Hépatogastroentérologie, CHU Trousseau, Tours, France.
  • Causse X; Department of Hepatology and Gastroenterology, Centre Hospitalier Régional (CHR), Orléans, France.
  • Geist C; Department of Hepatology and Gastroenterology, CHR, Metz, France.
  • Minello A; Department of Hepatology and Gastroenterology, University Hospital Dijon, INSERM UMR 1231, Dijon, France.
  • Rosa I; Department of Hepatology and Gastroenterology, Centre Hospitalier Intercommunal, Créteil, France.
  • Gelu-Simeon M; Service d'Hépato-Gastroentérologie, CHU de Pointe-à-Pitre, and Faculté de Médecine, Université des Antilles, Pointe-à-Pitre, Guadeloupe, France; INSERM, UMR-S1085, Institut de Recherche en Santé, Environnement et Travail (IRSET), Rennes, France.
  • Portal I; Service d'Hépato-Gastroentérologie, Hôpital de la Timone, Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Raffi F; Department of Infectious Diseases, Hotel-Dieu Hospital, INSERM CIC 1413, Nantes University Hospital, Nantes, France.
  • Bourliere M; Department of Hepatology and Gastroenterology, Hôpital Saint Joseph, Marseille, France.
  • Pol S; AP-HP, Hôpital Cochin, Unité d'Hépatologie, Paris, France; Université Paris Descartes, INSERM U1223 and USM-20, Institut Pasteur, Paris, France.
Lancet ; 393(10179): 1453-1464, 2019 Apr 06.
Article em En | MEDLINE | ID: mdl-30765123

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Carcinoma Hepatocelular / Hepatite C Crônica / Cirrose Hepática / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Carcinoma Hepatocelular / Hepatite C Crônica / Cirrose Hepática / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article